Compare · OPCH vs WGS
OPCH vs WGS
Side-by-side comparison of Option Care Health Inc. (OPCH) and GeneDx Holdings Corp. (WGS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both OPCH and WGS operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- OPCH is the larger of the two at $4.74B, about 2.5x WGS ($1.86B).
- WGS has been more active in the news (5 items in the past 4 weeks vs 4 for OPCH).
- OPCH has more recent analyst coverage (17 ratings vs 8 for WGS).
- Company
- Option Care Health Inc.
- GeneDx Holdings Corp.
- Price
- -
- -
- Market cap
- $4.74B
- $1.86B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2020
- News (4w)
- 4
- 5
- Recent ratings
- 17
- 8
Option Care Health Inc.
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides immunoglobulin infusion therapies for the treatment of immune deficiencies; anti-infective therapies and services; home infusion services to treat heart failures; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders; and immunoglobulin infusion therapies. It also offers infusion therapies for bleeding disorders; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications. In addition, the company offers therapies that women need to survive and thrive through high-risk pregnancies; treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; and nursing services. The company is headquartered in Bannockburn, Illinois.
Latest OPCH
- SEC Form 10-Q filed by Option Care Health Inc.
- Option Care Health Announces Financial Results for the Third Quarter Ended September 30, 2026
- Option Care Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- SEC Form PREM14A filed by Option Care Health Inc.
- SEC Form DEFA14A filed by Option Care Health Inc.
- SEC Form DEFA14A filed by Option Care Health Inc.
- SEC Form 8-K filed by Option Care Health Inc.
- CD&R and McKesson Corporation Sign Agreement to Acquire Option Care Health
- Option Care Health to Participate in Upcoming Investor Conferences
- Option Care Health downgraded by Deutsche Bank with a new price target
Latest WGS
- SEC Form SCHEDULE 13G filed by GeneDx Holdings Corp.
- GeneDx and Mirum Pharmaceuticals Launch Sponsored Testing Programs to Help Patients Find Answers Through Comprehensive Genetic Testing
- GeneDx to Report Third Quarter 2026 Financial Results on Monday, November 9, 2026
- GeneDx Expands Diagnostic Leadership with Long-Read Genome Sequencing, Advancing Rare Disease Diagnosis
- GeneDx Advances Clinical Adoption of Genomic Medicine with 27 Abstracts at ASHG 2026
- GeneDx Presents New Evidence Advancing Genomic Newborn Screening at ICoNS 2026
- GeneDx Introduces Easy Order at AAP 2026 to Simplify Genomic Testing in Everyday Pediatric Care
- CHIEF EXECUTIVE OFFICER Stueland Katherine converted options into 18,750 shares and sold $1,025,013 worth of shares (10,501 units at $97.61), increasing direct ownership by 8% to 115,476 units (SEC Form 4) (withholding obligation)
- CHIEF FINANCIAL OFFICER Feeley Kevin converted options into 7,197 shares and sold $363,892 worth of shares (3,728 units at $97.61), increasing direct ownership by 8% to 44,945 units (SEC Form 4) (tax withholding)
- Director Fuchs Thomas converted options into 1,146 shares (SEC Form 4)